Navega Therapeutics
Amanda Suhardjo is an accomplished scientist with a strong background in bioengineering and biomedical engineering. Currently serving as an Associate Scientist at Navega Therapeutics since July 2022, Amanda has previously held roles ranging from Research Associate to Senior Research Associate at the same company. Prior experience includes working as a Graduate Research Assistant at Prashant Mali Lab and as a Graduate Student at UC San Diego, where Amanda earned a Master of Science in Bioengineering. Additionally, Amanda completed a Bachelor of Science in Biomedical Engineering at the University of Southern California, where notable contributions included serving as Treasurer for Theta Tau-Kappa Epsilon Chapter and as a Webmaster for the Asian Pacific American Student Assembly. Amanda's early academic achievements include graduating as Class Valedictorian from Upland High School.
This person is not in any teams
Navega Therapeutics
Navega Therapeutics has developed a patented, non-permanent gene therapy to target pain that is non-addictive, highly specific, and long-lasting. Navega Therapeutics has imitated this process by utilizing a novel gene therapy to target pain in a non-permanent way.